Latest

AMD

Featured Neuroscience Visual Neuroscience

·June 25, 2026·14 min read

Mechanics of Color Vision Revealed

A structural biology study utilizing cryo-electron microscopy has resolved the first 3D structure of human blue and green cone opsins in their dark state, revealing that an open binding pocket in green opsins allows rapid retinal displacement for fast-updating daylight vision, while blue opsins require high-energy light due to a confined pocket.

Brain Cancer Featured Neuroscience Visual Neuroscience

·June 16, 2026·10 min read

Macular Degeneration Linked to Increased Risk of Cancer

A new study has established a significant biological link between neovascular age-related macular degeneration (nAMD) and a selective increased risk for specific malignancies.

Featured Neuroscience Visual Neuroscience

·March 30, 2026·6 min read

New Compounds Identified to Save Human Color Vision

Researchers screened 2,700 compounds on 20,000 human retinal organoids to find a way to stop cone cell death. They discovered that inhibiting casein kinase 1 can protect central vision from macular degeneration.

This shows a photoreceptor model, AI generated.

Featured Genetics Neuroscience Visual Neuroscience

·March 11, 2026·8 min read

Bringing Sight Back: Photoreceptor Cell Death Is Reversible

Scientists discover that dying eye cells can be rescued by clearing out "toxic batteries," potentially preventing permanent blindness.

This shows a pair of eye glasses next to an ashtray, symbolizing the connection between smoking and AMD.

Featured Genetics Neuroscience Visual Neuroscience

·February 27, 2026·9 min read

Cigarette Smoke Triggers Epigenetic Age Acceleration in the Eyes

Cigarette smoke doesn't just damage eye cells; it causes epigenetic shifts that "lock" the genes needed to prevent blindness and macular degeneration.

Featured Neuroscience Visual Neuroscience

·February 13, 2026·8 min read

How the Eye Develops Sharp Vision

Scientists have discovered that the human eye "rewires" itself during development to achieve sharp vision. This breakthrough could lead to new lab-grown transplants for macular degeneration.

Featured Neuroscience Visual Neuroscience

·October 20, 2025·10 min read

Electronic Eye Implant Restores Reading Vision in AMD

A groundbreaking European trial has shown that a new electronic eye implant, paired with augmented-reality glasses, can restore reading vision to patients blinded by geographic atrophy from dry age-related macular degeneration (AMD). The device, called the PRIMA System, enabled 84% of participants to read letters, numbers, and words through previously sightless eyes.

Featured Genetics Neuroscience Visual Neuroscience

·September 26, 2025·5 min read

mRNA Vaccine Targets Vision Loss in AMD

A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering hope for patients with age-related macular degeneration (AMD). Current treatments require repeated injections directly into the eye, but this vaccine can be delivered intramuscularly, making it less invasive and easier to administer.

Featured Genetics Neuroscience Visual Neuroscience

·September 23, 2025·4 min read

Human Stem Cell Transplants Boost Vision in Advanced Dry AMD

A new clinical trial suggests stem cell therapy may restore vision in people with advanced dry age-related macular degeneration, a disease that currently has no cure. Researchers transplanted retinal pigment epithelial stem cells, derived from adult postmortem eye tissue, into patients’ eyes.

Featured Genetics Neuroscience Visual Neuroscience

·July 18, 2025·3 min read

Innovative Therapies Help Restore Vision Loss in Macular Degeneration

Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment. Recently approved drugs, pegcetacoplan and avacincaptad pegol, target the complement system to slow dry AMD progression.

Brain Cancer Featured Neuroscience Visual Neuroscience

·July 14, 2025·4 min read

Cancer Drug Shows Promise In Treating AMD Vision Loss

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two major causes of blindness: wet age-related macular degeneration and diabetic retinopathy. Pre-clinical studies showed that intravenous PRL3-zumab reduced abnormal eye blood vessel leakage by 86% more than standard eye injections, with fewer risks.

Featured Genetics Neuroscience Visual Neuroscience

·June 24, 2025·7 min read

Could This Molecule Prevent Vision Loss in AMD?

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults. Researchers found that low ApoM impairs cholesterol metabolism in the retina, contributing to inflammation and vision loss—especially in advanced forms like geographic atrophy.